hold on there's just too much going on in Congress lmao...
Counts all out-of-pocket drug spending towards insurance deductibles and limits.
Rep. Murphy (R-PA) and others introduced this bill.
Introduced in House, awaiting committee review.
This bill mandates that any money you spend out-of-pocket on prescription drugs, even if you don't use your insurance benefits for that specific purchase, must count towards your health plan's deductible and out-of-pocket maximum. It amends the Public Health Service Act, ERISA, and the Internal Revenue Code. The bill was introduced by Mr. Murphy (R-PA) and several co-sponsors in the House of Representatives and referred to multiple committees for consideration.
Introduced Apr 14, 2026
The bill, H.R. 8270, was introduced in the House of Representatives on April 14, 2026. It has been sent to the House Committees on Energy and Commerce, Education and Workforce, and Ways and Means for review. For the bill to move forward, one or more of these committees would need to consider it, potentially hold hearings, and vote to send it to the full House for a vote. If passed by the House, it would then move to the Senate.
If this bill becomes law, any money you spend directly on prescription drugs, for example, using a discount card or paying cash at the pharmacy, would be added to the amount counted towards your health insurance deductible and annual out-of-pocket maximum. This means you might reach these limits quicker, potentially reducing how much you pay for other medical services later in the year. Health plans would be required to include these out-of-pocket drug costs when calculating your progress towards these financial limits for plan years starting on or after January 1, 2027.
Supporters Say
Supporters argue it makes healthcare more affordable by ensuring all patient drug spending contributes to cost-sharing limits.
Critics Say
Critics might raise concerns about increased administrative burdens for health plans or potential indirect effects on drug pricing structures.
Those in favor would highlight that the bill provides financial relief to patients, especially those with high prescription drug costs, by ensuring they get credit for all their spending towards their yearly insurance caps. It would prevent situations where patients pay cash for cheaper drugs, but those payments don't count towards their deductible. Some might express concerns about the administrative complexity for health insurance plans to track these various payments or the broader implications for how drug prices are calculated for government programs like Medicaid, although the bill includes specific amendments to address some of those calculations.